Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care

S Roversi, LM Fabbri, DD Sin… - American journal of …, 2016 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a global health issue with high social and
economic costs. Concomitant chronic cardiac disorders are frequent in patients with COPD …

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease

B Yeganeh, E Wiechec, SR Ande, P Sharma… - Pharmacology & …, 2014 - Elsevier
The cholesterol biosynthesis pathway, also known as the mevalonate (MVA) pathway, is an
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …

Comorbidities and systemic effects of chronic obstructive pulmonary disease

G Choudhury, R Rabinovich… - Clinics in chest …, 2014 - chestmed.theclinics.com
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It has been projected to move from the sixth to the third most common cause of …

Association between chronic obstructive pulmonary disease and cardiovascular disease in adults aged 40 years and above: data from NHANES 2013–2018

H Chen, X Luo, Y Du, C He, Y Lu, Z Shi… - BMC Pulmonary Medicine, 2023 - Springer
Background Chronic obstructive pulmonary disease (COPD) and cardiovascular disease
(CVD) are two major age-related diseases prevalent in the elderly. However, it is unclear …

Coronary artery disease concomitant with chronic obstructive pulmonary disease

S Roversi, P Roversi, G Spadafora… - European Journal of …, 2014 - Wiley Online Library
Background Numerous epidemiologic studies have linked the presence of chronic
obstructive pulmonary disease (COPD) to coronary artery disease (CAD). However …

Sex-specific and age-specific incidence of ischaemic heart disease, atrial fibrillation and heart failure in community patients with chronic obstructive pulmonary …

A Groenewegen, VW Zwartkruis… - BMJ open …, 2022 - bmjopenrespres.bmj.com
Objective To estimate the incidence of ischaemic heart disease, atrial fibrillation and heart
failure in community patients with or without chronic obstructive pulmonary disease (COPD) …

Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis

W Dalleywater, HA Powell, RB Hubbard, V Navaratnam - Chest, 2015 - Elsevier
OBJECTIVE People with idiopathic pulmonary fibrosis (IPF) have been shown to be at an
increased risk for cardiovascular (CV) disease, but reasons for this are unknown. The aim of …

[HTML][HTML] Idiopathic pulmonary fibrosis: clinical behavior and aging associated comorbidities

I Buendía-Roldán, M Mejía, C Navarro, M Selman - Respiratory Medicine, 2017 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible and usually lethal lung
disease of unknown etiology. Once considered as a relatively homogeneous, slowly …

Cardiovascular disease in patients with chronic obstructive pulmonary disease, obstructive sleep apnoea syndrome and overlap syndrome

A Voulgaris, K Archontogeorgis… - Current vascular …, 2021 - ingentaconnect.com
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome
(OSAS) are among the most prevalent chronic respiratory disorders. Accumulating data …

[HTML][HTML] Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients

Z Aisanov, N Khaltaev - Journal of thoracic disease, 2020 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is а highly prevalent, complex and
heterogeneous clinical condition which is associated with significant concomitant diseases …